CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-14 | GILBERT WALTER PHD Director | Sale | −7,500 | $33.19 | $249K | 27,243 |
| 2017-12-11 | DREISMANN HEINRICH Director | Sale | −6,000 | $33.50 | $201K | 33,743 |
| 2017-11-30 | Phanstiel S. Louise Director | Grant or award | +7,219 | 30,743 | ||
| 2017-11-30 | DREISMANN HEINRICH Director | Grant or award | +7,219 | 39,743 | ||
| 2017-11-30 | LANGER DENNIS Director | Grant or award | +7,219 | 39,743 | ||
| 2017-11-30 | GILBERT WALTER PHD Director | Grant or award | +7,219 | 34,743 | ||
| 2017-11-30 | HENDERSON JOHN T Director | Grant or award | +7,219 | 49,743 | ||
| 2017-11-30 | BEST LAWRENCE C Director | Grant or award | +7,219 | 39,743 | ||
| 2017-11-13 | Ford Alexander President, MGL | Sale | −3,031 | $31.64 | $96K | 76,769 |
| 2017-10-17 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −3,522 | $35.84 | $126K | 109,988 |
| 2017-10-04 | MARSH RICHARD M E.V.P., General Counsel | Gift | −1,500 | 136,385 | ||
| 2017-09-30 | Ford Alexander President, MGL | Returned to the company | −7,043 | $36.18 | $255K | 81,737 |
| 2017-09-30 | Ford Alexander President, MGL | Returned to the company | −1,937 | $36.18 | $70K | 79,800 |
| 2017-09-30 | Tobin Bernard President Crescendo BioScience | Returned to the company | −6,472 | $36.18 | $234K | 151,390 |
| 2017-09-30 | Tobin Bernard President Crescendo BioScience | Returned to the company | −5,218 | $36.18 | $189K | 146,172 |
| 2017-09-30 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −7,043 | $36.18 | $255K | 119,109 |
| 2017-09-30 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −5,599 | $36.18 | $203K | 113,510 |
| 2017-09-30 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −1,641 | $36.18 | $59K | 110,236 |
| 2017-09-30 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,052 | $36.18 | $74K | 108,184 |
| 2017-09-30 | Verratti Mark President Assurex Health Inc. | Returned to the company | −800 | $36.18 | $29K | 49,200 |
Page 45 of 60 · 1,194 trades